All ETFs

RYOAX

ETF

RYOAX · UNKNOWN · 75 holdings

59,95 €

▲ 1,15 € (1,96%)

Day Range

—

52-Week Range

—

Volume

—

Ouverture —

Moyenne 50J / 200J

—

Moyenne 50J / 200J

—

About RYOAX

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Prev. Close: 58,80 €
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 85.3%
HHI Score: 246,29
Top Sector: Healthcare (80.619467%)

Performance

Moderate (25,6%) ↘ Decelerating

▲ 1,08%

▲ 1,47%

▲ 3,25%

▲ 3,88%

YTD

▲ 3,66%

▲ 30,07%

▲ 5,15%

1M return (+1.47%) is stronger than 1W (+1.08%) — gains are slowing

Price History

Concentration Risk

38,69% Balanced

Diversified Concentrated

The top 10 holdings represent 38,69% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.

Top Holdings Today

Weighted by position size

ABBV

▼ -2,10%

AMGN

▼ -1,29%

GILD

▼ -2,18%

VRTX

▼ -2,34%

REGN

▼ -2,47%

CTA-PA

0,00%

ALNY

▲ 0,26%

BIIB

▼ -2,34%

Weighted avg. of top holdings ▼ -1,68%

Sector Allocation

Healthcare

80,62%

Manufacturing

4,23%

Top 10 Holdings

38,69% of fund

ABBV AbbVie Inc

7,87%

AMGN Amgen Inc

5,25%

GILD Gilead Sciences Inc

4,84%

VRTX Vertex Pharmaceuticals Inc

4,44%

REGN Regeneron Pharmaceuticals Inc

3,69%

CTA-PA Corteva Inc

3,14%

ALNY Alnylam Pharmaceuticals Inc

2,82%

BeiGene Ltd BeiGene Ltd

2,40%

AstraZeneca PLC AstraZeneca PLC

2,18%

BIIB Biogen Inc

2,04%

Other positions

0,67%

All Holdings (75)

Top 10: 38,69% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	ABBV	AbbVie Inc	7,87%	32 779	6,87 M
2	AMGN	Amgen Inc	5,25%	14 717	4,59 M
3	GILD	Gilead Sciences Inc	4,84%	37 674	4,22 M
4	VRTX	Vertex Pharmaceuticals Inc	4,44%	7 994	3,88 M
5	REGN	Regeneron Pharmaceuticals Inc	3,69%	5 077	3,22 M
6	CTA-PA	Corteva Inc	3,14%	43 585	2,74 M
7	ALNY	Alnylam Pharmaceuticals Inc	2,82%	9 122	2,46 M
8	BeiGene Ltd	BeiGene Ltd	2,40%	7 699	2,10 M
9	AstraZeneca PLC	AstraZeneca PLC	2,18%	25 870	1,90 M
10	BIIB	Biogen Inc	2,04%	13 038	1,78 M
11	NTRA	Natera Inc	1,99%	12 303	1,74 M
12	Royalty Pharma PLC	Royalty Pharma PLC	1,77%	49 676	1,55 M
13	UTHR	United Therapeutics Corp	1,74%	4 929	1,52 M
14	INSM	Insmed Inc	1,72%	19 715	1,50 M
15	BMRN	BioMarin Pharmaceutical Inc	1,68%	20 691	1,46 M
16	Intra-Cellular Thera	Intra-Cellular Therapies Inc	1,67%	11 075	1,46 M
17	ILMN	Illumina Inc	1,59%	17 445	1,38 M
18	NBIX	Neurocrine Biosciences Inc	1,53%	12 079	1,34 M
19	VTRS	Viatris Inc	1,45%	145 587	1,27 M
20	EXEL	Exelixis Inc	1,44%	34 137	1,26 M
21	EXAS	Exact Sciences Corp	1,36%	27 321	1,18 M
22	INCY	Incyte Corp	1,34%	19 286	1,17 M
23	ARGX	Argenx SE	1,32%	1 953	1,16 M
24	HALO	Halozyme Therapeutics Inc	1,31%	17 966	1,15 M
25	MRNA	Moderna Inc	1,29%	39 698	1,13 M
26	Alkermes PLC	Alkermes PLC	1,19%	31 357	1,04 M
27	Jazz Pharmaceuticals	Jazz Pharmaceuticals PLC	1,17%	8 239	1,02 M
28	BBIO	Bridgebio Pharma Inc	1,13%	28 613	989 151,41
29	GH	Guardant Health Inc	1,11%	22 653	965 017,8
30	TGTX	TG Therapeutics Inc	1,10%	24 299	958 109,57
31	LEGN	Legend Biotech Corp	1,09%	28 093	953 195,49
32	Blueprint Medicines	Blueprint Medicines Corp	1,09%	10 759	952 279,09
33	RVMD	Revolution Medicines Inc	1,08%	26 754	946 021,44
34	BNTX	BioNTech SE	1,08%	10 369	944 201,14
35	ADMA	ADMA Biologics Inc	1,00%	43 818	869 349,12
36	MEDP	Medpace Holdings Inc	0,99%	2 827	861 358,63
37	CYTK	Cytokinetics Inc	0,97%	20 961	842 422,59
38	IONS	Ionis Pharmaceuticals Inc	0,95%	27 488	829 312,96
39	ROIV	Roivant Sciences Ltd.	0,94%	81 405	821 376,45
40	AXSM	Axsome Therapeutics Inc	0,92%	6 919	806 962,97
41	SRPT	Sarepta Therapeutics Inc	0,91%	12 405	791 687,1
42	CRISPR Therapeutics	CRISPR Therapeutics AG	0,89%	22 773	774 965,19
43	PTCT	PTC Therapeutics Inc	0,81%	13 828	704 674,88
44	RARE	Ultragenyx Pharmaceutical Inc	0,79%	19 026	688 931,46
45	CRNX	Crinetics Pharmaceuticals Inc	0,78%	20 328	681 801,12
46	SpringWorks Therapeu	SpringWorks Therapeutics Inc	0,78%	15 390	679 160,7
47	Avidity Biosciences	Avidity Biosciences Inc	0,78%	22 941	677 218,32
48	PTGX	Protagonist Therapeutics Inc	0,73%	13 168	636 804,48
49	PCVX	Vaxcyte Inc	0,72%	16 618	627 495,68
50	FOLD	Amicus Therapeutics Inc	0,70%	74 384	606 973,44
51	VCYT	Veracyte Inc	0,69%	20 235	599 967,75
52	ACLX	Arcellx Inc	0,68%	9 039	592 958,4
53	APLS	Apellis Pharmaceuticals Inc	0,67%	26 577	581 238,99
54	VKTX	Viking Therapeutics Inc	0,67%	24 057	580 976,55
55	SMMT	Summit Therapeutics Inc	0,66%	30 008	578 854,32
56	ACAD	ACADIA Pharmaceuticals Inc	0,66%	34 621	575 054,81
57	TWST	Twist Bioscience Corp	0,65%	14 516	569 898,16
58	ASND	Ascendis Pharma A/S	0,63%	3 534	550 809,24
59	RXRX	Recursion Pharmaceuticals Inc	0,62%	102 430	541 854,7
60	DNLI	Denali Therapeutics Inc	0,57%	36 601	497 590,6
61	NUVL	Nuvalent Inc	0,57%	6 993	495 943,56
62	BEAM	Beam Therapeutics Inc	0,57%	25 359	495 261,27
63	Dynavax Technologies	Dynavax Technologies Corp	0,57%	38 117	494 377,49
64	MDGL	Madrigal Pharmaceuticals Inc	0,56%	1 488	492 870,24
65	AGIO	Agios Pharmaceuticals Inc	0,55%	16 450	481 985,0
66	ARWR	Arrowhead Pharmaceuticals Inc	0,54%	37 085	472 462,9
67	KRYS	Krystal Biotech Inc	0,52%	2 520	454 356,0
68	IDYA	Ideaya Biosciences Inc	0,51%	26 912	440 818,56
69	IMVT	Immunovant Inc	0,48%	24 485	418 448,65
70	CLDX	Celldex Therapeutics Inc	0,45%	21 816	395 960,4
71	IOVA	Iovance Biotherapeutics Inc	0,45%	118 443	394 415,19
72	DYN	Dyne Therapeutics Inc	0,43%	36 025	376 821,5
73	NVAX	Novavax Inc	0,41%	55 748	357 344,68
74	NTLA	Intellia Therapeutics Inc	0,34%	41 511	295 143,21
75	GERN	Geron Corp	0,29%	159 425	253 485,75

Showing top 10 of 75 holdings · Listed: 99,33% · 0,67% in other positions

Related ETFs

SCHX

Schwab U.S. Large-Cap ETF

Large Cap Ex-Mag 7 ETF

▼ -0,81%